HomeHAE • NYSE
Haemonetics Corp
add
$65.52
0.62%
After Hours:(0.00%)0.00
$65.52
Closed: Mar 14, 5:05:00 PM UTC-4 · USD · NYSE · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 348.54M | 3.66% |
Operating expense | 133.80M | 6.24% |
Net income | 37.49M | 20.02% |
Net profit margin | 10.76 | 15.82% |
Earnings per share | 1.19 | 14.42% |
EBITDA | 95.14M | 15.28% |
Effective tax rate | 24.89% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 322.58M | 65.32% |
Total assets | 2.53B | 15.04% |
Total liabilities | 1.62B | 29.22% |
Total equity | 906.86M | — |
Shares outstanding | 50.24M | — |
Price to book | 3.65 | — |
Return on assets | 6.54% | — |
Return on capital | 7.52% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 37.49M | 20.02% |
Cash from operations | 43.77M | 8,204.81% |
Cash from investing | -17.37M | 93.54% |
Cash from financing | 1.38M | -98.74% |
Net change in cash | 21.56M | 113.73% |
Free cash flow | 2.44M | 110.42% |
Previous close
$65.93
Day range
$65.28 - $67.03
Year range
$58.80 - $97.97
Market cap
3.29B USD
Avg Volume
1.23M
P/E ratio
25.78
Dividend yield
-
Primary exchange
NYSE
About
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
Founded
1971
Headquarters
Website
Employees
3,657
